Aging and Risk
Nir and Peter discuss the importance of balancing risk and reward when considering treatments for aging, including the potential benefits of immunity improvement and the safety profile of metformin. They explore the evolving regulatory environment and the need for adaptability in addressing the challenges of aging.In this clip
From this podcast
The Peter Attia Drive Podcast
#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19
Related Questions
What is Peter Attia's opinion on the use of Metformin for longevity purposes as discussed in the episode 204 - Centenarians, metformin, and longevity | Nir Barzilai, M.D. and the clip Study Design Challenges?
What is Peter Attia's opinion on the use of Metformin for longevity purposes in the episode 204 - Centenarians, metformin, and longevity | Nir Barzilai, M.D. and the clip Study Design Challenges?
What is Peter Attia's opinion on the use of Metformin for longevity purposes in the episode 204 - Centenarians, metformin, and longevity | Nir Barzilai, M.D. and the clip Aging and Disease?